Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02203136 · ClinicalTrials.gov registry record
Improving Clinical Staging for Muscle Invasive Bladder Cancer Through Molecular Profiling and Improved Imaging
A clinical trial, sponsored by M.D. Anderson Cancer Center.
- Completed
- Registry status
- 16
- Enrollment target
NCT02203136: Completed study, sponsored by M.D. Anderson Cancer Center.
NCT02203136 is a clinical trial that has completed, run by M.D. Anderson Cancer Center. The registered enrollment target is 16 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02203136 has completed, sponsored by M.D. Anderson Cancer Center.
- COMPLETED
- Registry status
- 16 participants
- Enrollment target
Study Summary
The goal of this research study is to improve detection of cancer outside of the bladder through genetic testing and improved imaging.
Interventions
- PROCEDURE Magnetic Resonance Imaging (MRI)
- PROCEDURE Tissue Biopsy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2014-06-25 |
| Est. Completion | 2019-05-16 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02203136
The ClinicalTrials.gov registry entry for NCT02203136 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 16 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Magnetic Resonance Imaging (MRI) is the first listed.
NCT02203136 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02203136 about?
NCT02203136 is a clinical study titled "Improving Clinical Staging for Muscle Invasive Bladder Cancer Through Molecular Profiling and Improved Imaging". The goal of this research study is to improve detection of cancer outside of the bladder through genetic testing and improved imaging.
What is the current status of trial NCT02203136?
This trial is currently completed. The enrollment target is 16 participants. The study started on 2014-06-25. Estimated completion is 2019-05-16.
What interventions are being tested in trial NCT02203136?
The interventions under investigation include: Magnetic Resonance Imaging (MRI) (PROCEDURE), Tissue Biopsy (PROCEDURE).
Who is sponsoring clinical trial NCT02203136?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.